2022 Impact of the SARS-CoV-2 pandemic on hematopoietic cell transplantation and cellular therapies in Europe 2020: a report from the EBMT activity survey Group COVID-19 Activity survey office 1st listed author Jakob R Passweg Journal Bone Marrow Transplant.
2022 Safe transfer of pediatric patients from hematopoietic stem cell transplant unit into the pediatric intensive care unit: views of nurses and physicians Group Paediatric Diseases Working Party (PDWP) Nursing Scientific Committee 1st listed author Daphna Hutt Journal Bone Marrow Transplant.
2022 Busulfan-fludarabine- or treosulfan-fludarabine-based myeloablative conditioning for children with thalassemia major Group Inborn Errors Working Party (IEWP) Paediatric Diseases Working Party (PDWP) 1st listed author Roswitha Lüftinger Journal Ann Hematol.
2022 Discrepancies in the management of Clostridioides difficile infections in patients after allogeneic haematopoietic cell transplantation: the results of the Infectious Diseases Working Party EBMT survey Group Infectious Diseases Working Party (IDWP) 1st listed author Agnieszka Piekarska Journal Bone Marrow Transplant.
2022 The first steps towards a diverse and inclusive EBMT: a position paper Group Patient Advocacy Committee Equality, Diversity & Inclusion (ED&I) Committee 1st listed author S Montoto Journal Bone Marrow Transplant.
2022 Hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome: an EBMT inborn errors working party analysis Group Inborn Errors Working Party (IEWP) 1st listed author Michael H Albert Journal Blood.
2022 Post-transplant cyclophosphamide in one-antigen mismatched unrelated donor transplantation versus haploidentical transplantation in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Giorgia Battipaglia Journal Bone Marrow Transplant.
2022 Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Juan-Carlos Hernández-Boluda Journal Bone Marrow Transplant.
2022 Total body irradiation plus fludarabine versus thiotepa, busulfan plus fludarabine as a myeloablative conditioning for adults with acute lymphoblastic leukemia treated with haploidentical hematopoietic cell transplantation. A study by the Acute Leukemia Working Party of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Ryszard Swoboda Journal Bone Marrow Transplant.
2022 Mother donors improve outcomes after HLA haploidentical transplantation: A Study by the Cellular Therapy and Immunobiology Working Party of the EBMT Group Cellular Therapy & Immunobiology Working Party (CTIWP) 1st listed author Loredana Ruggeri Journal Transplant Cell Ther.
2022 Busulfan-fludarabine- or treosulfan-fludarabine-based myeloablative conditioning for children with thalassemia major Group Inborn Errors Working Party (IEWP) Paediatric Diseases Working Party (PDWP) 1st listed author Roswitha Lüftinger Journal Ann Hematol.
2022 Cytogenetic risk classification maintains its prognostic significance in transplanted FLT3-ITD mutated acute myeloid leukemia patients: On behalf of the acute leukemia working party/European society of blood and marrow transplantation Group Acute Leukemia Working Party (ALWP) 1st listed author Arnon Nagler Journal Am J Hematol.